Azura Genomics
Private Company
Funding information not available
Overview
Azura Genomics is a private, commercial-stage company providing essential molecular biology reagents and consumables to the life sciences research and diagnostics markets. Leveraging over 20 years of experience in amplification technology, the company has built a portfolio centered on proprietary, optimized formulations that promise improved sensitivity, stability, and workflow simplicity. Operating a direct-to-customer e-commerce model from San Diego, Azura generates revenue through the sale of its branded reagent kits and its PURline consumables, while also offering custom OEM and bulk solutions. The company positions itself as a value-driven alternative to larger suppliers in the crowded but critical PCR reagents market.
Technology Platform
Proprietary formulations for PCR and qPCR mastermixes and enzymes, featuring optimized buffers with novel additives for complex samples, improved stability, low background DNA, stringent hot-start, and integrated workflow solutions for sensitivity and ease-of-use.
Opportunities
Risk Factors
Competitive Landscape
Azura competes in the crowded life science reagents market against giants like Thermo Fisher Scientific, Bio-Rad, and Qiagen, as well as numerous other specialized and generic suppliers. Its strategy is to differentiate on a value proposition of high sensitivity and ease-of-use at a competitive price point, targeting customers who may find premium brands cost-prohibitive or seek alternatives.